ÖZET:
Madde Kullanım Bozukluğu Tanıma Testi'nin (DUDIT) eroin bağımlısı erişkinlerde ve madde kullanım bozukluğu olan ergenlerde psikometrik özellikleri
INTRODUCTION
One of the several drug abuse screening instruments that have been developed to assess the severity of substance abusers' drug use 1 is the Drug Use Disorders Identification Test (DUDIT) 2 . The 11-item DUDIT was the result of an extensive literature review and think-aloud testing of three preliminary versions of the measure 2 . Developed as an analogous instrument to the Alcohol Use Disorders Identification Test (AUDIT) 3 , the questions on the DUDIT are parallel to those on the AUDIT with very few exceptions (i.e., two items on the AUDIT were deleted and three new items were added). The DUDIT assesses an individual's illicit drug use and related consequences over the past year and collects data in the following areas: (a) frequency of drug use, (b) drug-related problems, and (c) drug dependence symptoms. I n t h e i r i n i t i a l i n v e s t i g a t i o n o f t h e psychometric properties of the DUDIT, Berman et al. 2 used both general and clinical population samples. For the general population sample, the DUDIT was administered to 1109 randomly selected individuals from the Swedish Population Registry. Using this sample, a Cronbach's alpha of 0.93 was found. Based on their data, the authors recommend that scores of 6 for males and 2 for females be used as cutoff values suggestive of drug-related problems in the general population 4 . The clinical population consisted of 160 individuals, who were either inpatients at an addiction detoxification unit, prison detainees, prison inmates, or probation clients. In this sample, the DUDIT yielded a Cronbach's alpha of 0.80. Consequently, the authors suggested that scores greater than 25 be used as the cut-off for identifying individuals in clinical populations, who are likely to meet substance dependence criteria 2, 4 . Subsequent articles have reported mean (SD) DUDIT scores in substance abusing samples ranging from 16.9 (9.8) for dependent substance abusers who had relapsed 5 to 31.9 (6.1) for inpatient opiate abusers 6 . The latter study also found that 88% of this known substance abusing sample scored greater than 25 points on the DUDIT, suggesting that the measure was useful in detecting substance dependence in this population.
Psychometric evaluations of the DUDIT have been mostly studied in Europe (three in Sweden, one in Norway, one in England) with severely dependent drug abusers in highly constrained settings (e.g., detoxification and inpatient units, prisons) 2, [5] [6] [7] [8] [9] [10] [11] [12] . The measure was also evaluated with less severe substance abusing clinical populations in the United States of America (USA) 13 . All these studies supported the construct of the DUDIT, which was found to be a psychometrically sound drug abuse screening measure with high convergent validity and good discriminant validity. Additional to these, in a sample of 181 Swedish suspected offenders with signs of mental health problems, the DUDIT showed high accuracy for identification of dependency diagnoses and was associated with drug and legal problem severity as a screening tool 14 . Finally, a study conducted in patients with first-episode psychosis in Norway suggested that the DUDIT was a powerful screening instrument (Cronbach's alpha 0.93 for men and 0.96 for women) for detecting drug use disorders in this population 15 . Consistent with these the DUDIT was one of the 13 instruments suggested as being useful in general hospital wards as a screening tool 1 . Although a variety of drug use measures currently exist, the DUDIT has several advantages over other instruments. For example, unlike the Addiction Severity Index 16 , the DUDIT's administration time is brief (<5 mins) and it is easy to score. Also, unlike some drug screening measures that inquire about lifetime use (e.g., Cutdown Annoy Guilty Eye-opener Adapted to Include Drugs [CAGE-AID]) 17 , the DUDIT focuses on drug use and drug-related consequences occurring within the past year, thus identifying possible diagnosable drug use problems. Another advantage is that unlike dichotomous scaling (used by the Drug Abuse Screening Test 18 and CAGE-AID 17 ), the questions on the DUDIT are scored using continuous interval scaling which has been found to reduce underreporting of drug use and related consequences 3 . Although the AUDIT has been used widely for alcohol use disorders in Turkey in the last decade 3, 19 , currently there is no instrument to measure or detect the presence and severity of drug use disorder. In an effort to filling this gap, the aim of the present study was to evaluate the psychometric properties of the DUDIT 2 , an 11-item self-reported questionnaire developed previously to screen individuals for drug problems, in Turkish patients with drug use disorder.
METHODS

Participants
The data were gathered from two treatment centers in Bakirkoy Training and Research Hospital for Psychiatry, Istanbul, Neurology and Neurosurgery.
Adolescents with drug use disorder (n=100) were recruited from inpatients admitted to the Child and Adolescent Substance Treatment and Training Center (CEMATEM), whereas heroin dependents (n=123) and alcohol dependents (n=35) were recruited from the inpatients admitted to the Alcohol and Drug Research Training and Treatment Center (AMATEM). Thus the inclusion criterion was to be an inpatient in these clinics, whereas there were no exclusion criteria for the sample, since these criteria were applied during the admission (e.g., patients with severe psychopathology and/or cognitive deficiency were not admitted). Participants were grouped according to their diagnoses as (a) adolescents with drug use disorder (ADUD; n=100), (b) residential heroin dependents (RHD; n=123) or (c) alcohol dependents without a drug abuse problem (AD; n=35). The third group was included to evaluate the discriminant validity of the DUDIT. Group membership was based on the substance use disorder module of the Turkish version of the Structured Clinical Interview for the DSM-IV (SCID-I) 20, 21 , which was conducted by a psychiatrist who was experienced with the administration of this instrument (C.E.). The AD group did not report any drug use, whereas the RHD and the ADUD groups did not have an alcohol use disorder diagnosis. The patient's written informed consent was obtained after the study protocol was thoroughly explained.
Translation
The original AQ was independently translated from English into Turkish by two experts in psychiatry. Consensus was reached on a common draft by these experts. This Turkish version was back translated into English by an independent translator.
Measures
Participants at both adolescent and adult treatment programs completed the DUDIT, the DAST-10 and a short questionnaire gathering demographic and substance abuse history information.
The DAST-10
The DAST-10 was selected as a comparison measure for the DUDIT because it is frequently used in the drug abuse field and has demonstrated sound psychometric properties 22 . The DAST assesses drug consequences and problem severity in the past year 18 . The original 28-item DAST, modeled after the Michigan A l c o h o l i s m S c r e e n i n g Te s t 2 3 , h a s a unidimensional construct when factor analyzed 18 . All versions of the DAST (28-, 20-and 10-item) have been found to have moderate to high levels of validity, sensitivity, and specificity 22 . Since the 10-item version of the DAST (DAST-10) has comparable sensitivity and specificity to its 28-and 20-item counterparts 1 , the former was used in the present study. For the DAST-10, scores range from 0 to 10. The Turkish version has a Cronbach's alpha of 0.90 and a single component accounted for 59.35% of total variance. Additionally, DAST-10 showed good discriminant validity as it significantly differentiated patients with drug use disorder from alcohol dependents 24 .
DUDIT
The DUDIT is an 11-item self-reported questionnaire that was developed to screen individuals for drug problems. As the development and psychometric properties of the DUDIT have been described earlier in the Introduction section, they will not be repeated here. The first nine questions are scored on 5-point scales ranging from 0 to 4, and the last two are scored on 3-point scales with values of 0, 2, and 4. Thus, total scores range from 0 to 44, with higher scores suggestive of a more severe drug problem.
Statistical Analyses
The following strategies were used to investigate the psychometric properties of the DUDIT: (a) convergent validity was evaluated by calculating a Pearson product-moment correlation between the DUDIT and the DAST-10; (b) internal consistency reliability was assessed using Cronbach's alpha and test-retest correlation was used only for the RHD group; (c) factor structure was examined using a principal component analysis (PCA); (d) predictive validity, sensitivity, specificity, and optimal cut-off scores were estimated by constructing a Receiver Operating Characteristic (ROC) curve; and (e) discriminant validity was evaluated using a one-way analysis of variance (ANOVA) of DUDIT scores for the three groups of participants. Table 1 presents demographic and substance abuse history variables for the three groups of participants (ADUD, RHD, and AD).
RESULTS
Factor Structure
To explore the factor structure of the DUDIT, a PCA was performed using all participants (n=258) and for rotation method Varimax with Kaiser normalization was used. Criteria for retaining extracted components on the PCA were: (a) visual inspection of the scree plot to note breaks in size of Eigenvalues between the components, (b) Eigenvalues greater than one, and (c) percentage of variance accounted for by components retained.
To explore construct validity of the scale first exploratory factor analysis than confirmatory factor analysis were conducted. Prior to any further analysis, the adequacy of sample size was verified using the Keiser-Meyer-Olkin (KMO) measurement of sampling adequacy, which was acceptable at 0.93.
A visual inspection of the scree plot revealed two components accounting for the majority of variance before components started to level off. Two components on the DUDIT reached the criterion of an Eigenvalue greater than one (6.45 and 1.12) and the variance accounted for by these components were 58.65% and 10.20% respectively. In the twofactor solution of the principal components analysis, the first eigen value (6.45) was larger than three times of the second eigen value (1.12). Thus, the output for the two-factor solution indicates a unidimensional construct for the measure. The unidimensionality of As seen in Table 2 , all item-component loadings were higher than 0.30 and were in the "good" (0.47) to "excellent" (0.83) range. Thus, results from the PCA suggest that the DUDIT assesses a unidimensional construct.
Convergent Validity and Internal Consistency Reliability
The Pearson product-moment correlation between the DUDIT and DAST-10 scores for all participants (n=258) was high (r=0.76, p<0.001). Internal consistency reliability for the DUDIT, examined by Cronbach's alpha, was also very high (coefficient α=0.93) ( Table 2 ). Coefficient of test-retest in the heroin dependent group was r = 0 . 7 7 , p < 0 . 0 0 1 . C o r r e c t e d i t e m t o t a l correlations for the DUDIT in the total sample are shown in Table 2 . Also inter-item and itemtotal correlations for the DUDIT are shown in Table 3 . The DUDIT's predictive validity, sensitivity, and specificity were examined using a ROC curve that included all participants (n=258). Participants were dichotomously classified according to the SCID-I as a group with alcohol use disorder or a group with drug use disorder. Results revealed that the area under curve (AUC) (0.975-Std. Error=0.018) was in the "excellent" range and that a score of 10 was the most critical value for identifying a participant as having a drug problem. As seen in Table 4 , this cut-off score corresponds to sensitivity and specificity values of 0.96 and 0.94, respectively. Table 5 shows the comparison of alcohol use disorders with drug use disorders according to the cut-off point 10 on the DUDIT and mean scores of the DUDIT.
Tab le 2: Item-component loadings and corrected item-total correlations for the Drug Use Disorders Identification Test (DUDIT). (n=258)
Concurrent Validity
To evaluate concurrent validity, a one-way ANOVA was conducted using the total mean score on the DUDIT as the dependent variable and the participants' group membership (ADUD, RHD, AD) as the independent variable. The assumptions of homogeneity of variance and normal distribution of scores were tenable. The result of ANOVA for the D U D I T w a s s t a t i s t i c a l l y s i g n i f i c a n t , F (2,255)=223.42, p<0.001. Post-hoc analysis using Tukey's procedure revealed that the mean (SD) DUDIT score for the RHD group, 35.26 (6.77) was higher than the scores in both the ADUD group, 23.52 (10.27), p<0.001 and the AD group, 2.17 (7.01). Finally, the DUDIT mean score was significantly higher in the ADUD group as compared to the AD group (p<0.001).
DISCUSSION
The DUDIT was developed to identify individuals in the general public, who may have a drug problem as well as individuals in clinical settings, who are likely to meet criteria for a substance dependence diagnosis 2 . Previous studies were mostly conducted in Europe and only one study was conducted in the USA. The present study extended the evaluation of the psychometric properties of the DUDIT to treatment seeking patients with drug use disorder in Turkey.
Overall, the DUDIT was found to have satisfactory psychometric characteristics as a drug abuse screening test. Consistent with a previous study 13 conducted in the USA (r=0.85), the instrument's high correlation with DAST-10 indicated a good convergent validity (r=0.76). The DUDIT also showed good discriminant validity as evidenced by its ability to significantly differentiate drug use disorders from alcohol dependents. Also, similar to the study conducted in the USA (0.94) 13 and higher than the original study (0.80) 2 , the Turkish version of the scale had high internal consistency reliability (Cronbach's alpha=0.93). Finally, PCA for the DUDIT produced a unidimensional construct, with a single component accounting for 58.65% of the total variance. This rate was 64.91% in the USA study 13 . In the present study, using Confirmatory Factor Analyses provided further support for the unidimensional structure of the DUDIT. The ROC curve showed that the DUDIT had good predictive validity as suggested by high sensitivity, specificity, and the AUC. Results revealed that a cut-off score of 10 was the most critical value for identifying participants as having an drug use disorder according to the SCID-I. While this cutoff point was similar in the USA study (cut-off score of 8) 13 , it was lower when compared to that of the Swedish study (cut-off score of 25) 2 . This difference can be explained by the sample difference that the present study included an adolescent sample with less severe drug abuse histories than the Swedish study 2 and similarto that of the USA study 13 . Indeed, the sample of the present study was more similar to the USA study (which included patients with drug use disorder and alcohol use disorder), rather than the Swedish study (which included a sample of heavy drug users from prison, probation, and inpatient detoxification settings, and a general Swedish population sample). Also in a study conducted in a sample of 181 Swedish suspected offenders Durbeej et al.
14 suggested that cutoff scores should be applied with caution due to the discrepancy between studies.
In previous studies conducted among substance abusing samples mean (SD) DUDIT scores were 16.9 (9.8) for substance abusers who had relapsed 5 , 31.9 (6.1) for inpatient opiate abusers, 23.5 (11.0) for outpatient drug abusers and 26.0 (12.4) for residential drug abusers 13 . These mean scores were consistent with the present study that mean (SD) DUDIT scores were 23.5 (10.3) for adolescents with drug use disorder and 35.3 (6.8) for adults with heroin dependence.
In addition to having good psychometric characteristics, the DUDIT has an advantage over other drug abuse screening instruments, because it is brief, not substance specific, and inquires about use and consequences within the past 12 months, consistent with the DSM-IV-TR interval criterion for diagnosis. As compared to the DAST-10, the DUDIT has the advantage of gathering information about quantity and frequency of drug use. The present study has one main limitation, which concerns the homogeneity of the sample. Specifically, about half of all drug abusers in the present study were adults dependent to heroin and the other half were adolescents with different drug use disorders. There were no female participants in the ADUD and AD groups and data could have been collected from healthy controls as well. The sample size was adequate for the analyses, but larger studies may provide better results. Thus, future research will need to evaluate the DUDIT's characteristics using a larger and more heterogeneous sample of both female and male drug abusers. Finally test-retest reliability was only conducted for the RHD group, whereas it should have been conducted also for the ADUD group.
In conclusion, the present study extended the evaluation of the psychometric properties of the DUDIT to both adult and adolescent populations with drug use disorder and supported the unidimensional construct of the DUDIT in Turkish patients with drug use disorder. This and previous studies support the use of the DUDIT in various clinical settings and encourage continued research into its use.
